We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

New Process Analyzes Predominant SARS-CoV-2 Mutations as Well as Possible New Virus Variants

By LabMedica International staff writers
Posted on 21 Jan 2021
Print article
Image: Click Tech Single Strain Mutation Mapping Kit for SARS-CoV-2 (Photo courtesy of baseclick GmbH)
Image: Click Tech Single Strain Mutation Mapping Kit for SARS-CoV-2 (Photo courtesy of baseclick GmbH)
A new and more efficient process has been developed to determine not only predominant SARS-CoV-2 mutations but also minor occurring mutations in the virus population which might become eventually new strains.

The Click Tech Single Strain Mutation Mapping Kit for SARS-CoV-2 developed by baseclick GmbH (Munich, Germany), together with “long-read” sequence methods, such as those provided by Pacific Biosciences (Menlo Park, CA, USA) allows an exact genomic assignment and an assessment of the frequency of newly-emerging virus variants in the population. With the analysis method, it is also possible to identify all SARS-CoV-2 mutations within a COVID-19 patient, including those over the course of the disease.

The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in the UK and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties. Most of the approximately 12,000 mutations in the genome of the SARS-CoV-2 virus that have been identified since February 2020 so far did not change the biological properties of the virus. However, some of the almost 4,000 mutations that have been identified in the spike protein (S-Protein) have influenced the biological properties infectivity, disease progression and immunogenicity of the mutant SARS-CoV-2 virus. It is increasingly important to contain and manage the infection progress not only by detection of aSARS-CoV-2 infection e.g. by PCR, but also to carry out a genetic analysis of the infecting strain.

Currently, genetic analysis of SARS-CoV-2 is based on the Amplicon methods. The genome part responsible for infectivity, disease progression and immunogenicity is dissected into small sections and subsequently sequenced. Mutations and thus, possible new virus variants are determined using mathematical methods. In contrast, baseclick offers a kit that generates first a 1:1 cDNA copy of the entire 30,000 base-long SARS-CoV-2 mRNA genome, irrespective of the strain involved. Secondly, overlapping genomic fragments up to 4.2 kb are amplified of critical S-E-M-N coding genome part. When coupled with existing long-read NGS technologies, these long DNA fragments can even be used to precisely distinguish and characterize multiple SARS-CoV-2 variants. This can be used to predict e.g. genome plasticity, presents of multiple strains in a patient, mutation accumulation during infection in patients, etc.

“It is good news that baseclick has now developed a highly efficient analysis method to analyze SARS-CoV-2 mutations since the increased occurrence of new SARS-CoV-2 virus strains,” said baseclick CEO Dr. Thomas Frischmuth. “With our sequencing kit, the genome section responsible for infectivity, disease progression and immunogenicity is directly analyzed and mutations can be assigned directly without any intermediate mathematical steps.”

“Research into the SARS-CoV-2 mutations and emerging virus strains is just beginning. More knowledge about this will support vaccine development, therapies and the management of this pandemic, and we are making a new and decisive contribution to this,” added Dr. Frischmuth.

Related Links:
baseclick GmbH
Pacific Biosciences

Gold Supplier
SARS-CoV-2 (COVID-19) Antibody Test
SARS-CoV-2 Antigen Test
ESPLINE SARS-CoV-2 Antigen Test
Influenza & COVID-19 Test
Influenza & COVID-19 Ag Combo Rapid Test Cassette (Swab)
Gold Supplier
Clinical Chemistry Series
Clinical Chemistry Series

Print article


Molecular Diagnostics

view channel
Image: Micrograph of a colorectal adenocarcinoma (Photo courtesy of Wikimedia Commons)

Plasma or Urine Liquid Biopsy Tests May Guide Colorectal Cancer Treatment

A recent paper suggested that liquid biopsy examination of blood or urine could aid in evaluating the effectiveness of therapy for colorectal cancers that had begun to metastasize beyond the site of the... Read more


view channel
Image: Sysmex CN-Series automated blood coagulation analyzer (Photo courtesy of Sysmex Corporation)

Siemens and Sysmex Extend Agreement to Provide One of the Largest Portfolios of Hemostasis Testing Systems and Reagents

Siemens Healthineers (Erlangen, Germany) and Sysmex Corporation (Kobe, Japan) have renewed their long-standing global supply, distributorship, sales and service agreement for a broad portfolio of hemostasis... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.